Comparison of Two Different Treatment Methods

Not Applicable

Completed

• Conditions: Musculoskeletal Diseases; Subacromial Impingement Syndrome; Musculoskeletal Pain; Musculoskeletal Injury; Weakness, Muscle
• Interventions: Other: Kinesiotaping; Other: Mulligan Mobilization Technique

• Registration Number: NCT05071469
• Lead Sponsor: Banu BAYAR

Brief Summary

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Detailed Description

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

Study Timeline

• Study Start: 2021-09-28
• Study First Submitted: 2021-09-28
• Study First Submitted QC: 2021-09-28
• Study First Posted: 2021-10-08
• Primary Completion: 2021-10-15
• Study Completion: 2021-11-30
• Status Verified: 2022-12
• Last Update Submitted: 2022-12-19
• Last Update Posted: 2022-12-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Impingement symptoms in clinical tests
• Pain >1 month

Exclusion Criteria

• Any shoulder pathology.
• Have chronic systemic diseases or infections.
• History of any surgery shoulder complex.
• steroid injections and therapeutic approaches

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Kinesiotaping Group (KG)	Kinesiotaping	Experimental group
Mulligan Mobilization Technique Group (MG)	Mulligan Mobilization Technique	Experimental group (2)

Primary Outcome Measures

Name	Time	Method
Change of pain severity	Baseline- after 2 weeks (after treatment)	Via VAS.
Change of Range of Motion	Baseline- after 2 weeks (after treatment)	Via goniometer.
Change of Functionality	Baseline- after 2 weeks (after treatment)	Via SPADI.

Secondary Outcome Measures

Name	Time	Method
Change of Satisfaction of Life	Baseline- after 2 weeks (after treatment)	Via SWLS.
Change of Satisfaction of Treatment	Baseline- after 2 weeks (after treatment)	Via VAs.
Change of Sleep Quality	Baseline- after 2 weeks (after treatment)	Via VAS.

Trial Locations

Locations (1)

Muğla Sıtkı Koçman University; 🇹🇷 Muğla, Turkey